⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SKYX News
SKYX Platforms Corp. Common Stock
SKYX to Participate in the 38th Annual ROTH Conference
globenewswire.com
SKYX
SKYX Announces it will Supply its Technologies to Enable a New Contemporary Apartment Community in New York as it Continues to Grow its Market Penetration
globenewswire.com
SKYX
SKYX Announces it will Supply its Technologies to Enable a New Contemporary Apartment Community in New York as it Continues to Grow its Market Penetration
globenewswire.com
SKYX
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
accessnewswire.com
CJMB
DHX
DXR
ELWT
FLNT
GSIT
NTWK
OMEX
SKYX
LODE
BCHT
CITR
Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
prnewswire.com
SKYX
SKYX Provides Corporate Update including New Product Launches, NVIDIA Collaboration, and $29 Million in Recent Investments from Fundamental Institutions
globenewswire.com
SKYX
SKYX Announces Launch at Walmart, U.S. Leading Retailer, of its Ceiling Plug & Play SKYFAN & TURBO HEATER
globenewswire.com
SKYX
SKYX Announces Launch at Home Depot of its Ceiling Plug & Play SKYFAN & TURBO HEATER, including a Launch of a Dedicated SkyPlug Branding Page at HomeDepot.com
globenewswire.com
SKYX
Skyhawk Therapeutics gibt Neun-Monats-Zwischenergebnisse bei Patienten aus der klinischen Phase-1-Studie mit SKY-0515 zur Behandlung der Huntington-Krankheit bekannt USA - Deutsch USA - español USA - Polski Vietnam - Vietnamese APAC - English Korea - 한국어
prnewswire.com
SKYX
Skyhawk Therapeutics annonce les résultats intermédiaires à neuf mois de son essai clinique de Phase 1 du SKY-0515 comme traitement de la maladie de Huntington USA - Français USA - español USA - Polski Vietnam - Vietnamese APAC - English Korea - 한국어 USA -
prnewswire.com
SKYX